222 related articles for article (PubMed ID: 7909419)
1. In vitro antiproliferative activity of docetaxel (Taxotere), paclitaxel (Taxol) and cisplatin against human tumour and normal bone marrow cells.
Braakhuis BJ; Hill BT; Dietel M; Kelland LR; Aapro MS; Zoli W; Lelieveld P
Anticancer Res; 1994; 14(1A):205-8. PubMed ID: 7909419
[TBL] [Abstract][Full Text] [Related]
2. Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines.
Kelland LR; Abel G
Cancer Chemother Pharmacol; 1992; 30(6):444-50. PubMed ID: 1356649
[TBL] [Abstract][Full Text] [Related]
3. In vitro cytotoxic activity of Taxol and Taxotere on primary cultures and established cell lines of human ovarian cancer.
Silvestrini R; Zaffaroni N; Orlandi L; Oriana S
Stem Cells; 1993 Nov; 11(6):528-35. PubMed ID: 7906583
[TBL] [Abstract][Full Text] [Related]
4. Taxane sensitivity of ovarian carcinoma in vitro.
Engblom P; Rantanen V; Kulmala J; Heiskanen J; Grenman S
Anticancer Res; 1997; 17(4A):2475-9. PubMed ID: 9252666
[TBL] [Abstract][Full Text] [Related]
5. The scientific rationale for developing taxoids.
Aapro M
Anticancer Drugs; 1996 Aug; 7 Suppl 2():33-6. PubMed ID: 8862709
[TBL] [Abstract][Full Text] [Related]
6. Interaction of ionizing radiation with paclitaxel (Taxol) and docetaxel (Taxotere) in HeLa and SQ20B cells.
Hennequin C; Giocanti N; Favaudon V
Cancer Res; 1996 Apr; 56(8):1842-50. PubMed ID: 8620502
[TBL] [Abstract][Full Text] [Related]
7. In vitro activity of taxol and taxotere in comparison with doxorubicin and cisplatin on primary cell cultures of human breast cancers.
Zoli W; Flamigni A; Frassineti GL; Bajorko P; De Paola F; Milandri C; Amadori D; Gasperi-Campani A
Breast Cancer Res Treat; 1995 Apr; 34(1):63-9. PubMed ID: 7749161
[TBL] [Abstract][Full Text] [Related]
8. Effects of Taxotere and taxol on in vitro colony formation of freshly explanted human tumor cells.
Hanauske AR; Degen D; Hilsenbeck SG; Bissery MC; Von Hoff DD
Anticancer Drugs; 1992 Apr; 3(2):121-4. PubMed ID: 1356030
[TBL] [Abstract][Full Text] [Related]
9. Docetaxel and paclitaxel inhibit DNA-adduct formation and intracellular accumulation of cisplatin in human leukocytes.
Ma J; Verweij J; Planting AS; Kolker HJ; Loos WJ; de Boer-Dennert M; van der Burg ME; Stoter G; Schellens JH
Cancer Chemother Pharmacol; 1996; 37(4):382-4. PubMed ID: 8548886
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of endothelial cell function in vitro and angiogenesis in vivo by docetaxel (Taxotere): association with impaired repositioning of the microtubule organizing center.
Hotchkiss KA; Ashton AW; Mahmood R; Russell RG; Sparano JA; Schwartz EL
Mol Cancer Ther; 2002 Nov; 1(13):1191-200. PubMed ID: 12479700
[TBL] [Abstract][Full Text] [Related]
11. Cytotoxic effects toward human hematopoietic progenitor cells and tumor cell lines of paclitaxel, docetaxel, and newly developed analogues IDN5109, IDN5111, and IDN5127.
Ferlini C; Distefano M; Pierelli L; Bonanno G; Riva A; Bombardelli E; Ojima I; Mancuso S; Scambia G
Oncol Res; 1999; 11(10):471-8. PubMed ID: 10850888
[TBL] [Abstract][Full Text] [Related]
12. Differential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro.
Hill BT; Whelan RD; Shellard SA; McClean S; Hosking LK
Invest New Drugs; 1994; 12(3):169-82. PubMed ID: 7896535
[TBL] [Abstract][Full Text] [Related]
13. In vitro cytotoxicity of docetaxel in childhood acute leukemias.
Consolini R; Pui CH; Behm FG; Raimondi SC; Campana D
J Clin Oncol; 1998 Mar; 16(3):907-13. PubMed ID: 9508172
[TBL] [Abstract][Full Text] [Related]
14. [Taxotere: from yew's needles to clinical practice].
Lavelle F; Gueritte-Voegelein F; Guenard D
Bull Cancer; 1993 Apr; 80(4):326-38. PubMed ID: 7909695
[TBL] [Abstract][Full Text] [Related]
15. Antitumor effect and potentiation of cytotoxic drugs activity in human cancer cells by ZD-1839 (Iressa), an epidermal growth factor receptor-selective tyrosine kinase inhibitor.
Ciardiello F; Caputo R; Bianco R; Damiano V; Pomatico G; De Placido S; Bianco AR; Tortora G
Clin Cancer Res; 2000 May; 6(5):2053-63. PubMed ID: 10815932
[TBL] [Abstract][Full Text] [Related]
16. Effect of docetaxel with cisplatin or vinorelbine on lung cancer cell lines.
Aoe K; Kiura K; Ueoka H; Tabata M; Matsumura T; Chikamori M; Matsushita A; Kohara H; Harada M
Anticancer Res; 1999; 19(1A):291-9. PubMed ID: 10226557
[TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation of docetaxel (Taxotere).
Lavelle F; Bissery MC; Combeau C; Riou JF; Vrignaud P; André S
Semin Oncol; 1995 Apr; 22(2 Suppl 4):3-16. PubMed ID: 7740328
[TBL] [Abstract][Full Text] [Related]
18. Paclitaxel (Taxol) and docetaxel (Taxotere): not simply two of a kind.
Verweij J; Clavel M; Chevalier B
Ann Oncol; 1994 Jul; 5(6):495-505. PubMed ID: 7918121
[TBL] [Abstract][Full Text] [Related]
19. Taxol and taxotere in bladder cancer: in vitro activity and urine stability.
Rangel C; Niell H; Miller A; Cox C
Cancer Chemother Pharmacol; 1994; 33(6):460-4. PubMed ID: 7907952
[TBL] [Abstract][Full Text] [Related]
20. No cross-resistance of taxotere and taxol to conventional chemotherapeutic agents against gastric cancers as detected by MTT assay.
Maeda S; Saikawa Y; Kubota T; Aoki M; Otani Y; Furukawa T; Watanabe M; Kumai K; Kitajima M
Anticancer Res; 2003; 23(4):3147-50. PubMed ID: 12926047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
